Nistala Kiran 4
4 · Zura Bio Ltd · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Zura Bio Insider Nistala Kiran Receives 340,900-Share Option Award
What Happened
Nistala Kiran (role not specified in the filing) was granted a derivative equity award covering 340,900 shares of Zura Bio Ltd (ZURA) on April 1, 2026. The Form 4 reports the acquisition as an award (transaction code A) at $0.00 per share, so no cash changed hands and no sale or exercise was reported.
Key Details
- Transaction date: 2026-04-01; Form 4 filed: 2026-04-02 (timely filing).
- Type: Award/Grant of a derivative security (reported as 340,900 shares at $0.00).
- Shares owned following transaction: Not stated in the provided excerpt.
- Footnote (F1): Vesting — one-fourth vests on April 1, 2027, then one-twelfth of the remainder vests in equal quarterly installments thereafter, subject to continued service.
- No exercise or sale reported (this is a grant, not a purchase or disposition).
Context
The filing reflects a compensation grant (an option award per the footnote) that vests over time; it does not indicate an immediate purchase or sale by the insider. Grants like this are common for employee/executive compensation and primarily signal future potential ownership contingent on vesting and possible exercise terms.
Insider Transaction Report
- Award
Employee Share Option (Right to Buy)
[F1]2026-04-01+340,900→ 340,900 totalExercise: $6.03Exp: 2036-04-01→ Class A Ordinary Shares (340,900 underlying)
Footnotes (1)
- [F1]One fourth (1/4th) of the shares subject to the option award shall vest on April 1, 2027, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.